This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (10)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Alfonso Ceccherini Nelli, MD; Paul E. Yarden, MD
Veterans Administration Medical Center Northport, NY 11768

Mario Guazzelli, MD
University of Pisa 56100 Pisa, Italy

Irwin Feinberg, MD
Veterans Administration Medical Center Northport, NY 11768 and State University of New York-Health Science Center at Stony Brook Stony Brook, NY 11794

Arch Gen Psychiatry. 1989;46(4):383-384.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

We investigated effects of abrupt neuroleptic withdrawal (NW) in patients receiving long-term treatment to explore the phenomenology of tardive dyskinesia (TD) elicited or exacerbated by this maneuver. We expected neuroleptic-induced parkinsonism to improve or disappear, although we were aware of cases where it persisted for lengthy periods.^1-4 To our surprise, we found that NW was associated with the onset or worsening of Parkinson's disease symptoms in six of 15 patients.

Subjects and Methods.—

Subjects were male patients hospitalized on a long-term basis, and gave informed consent; 11 were studied at the Veterans Administration Medical Center, Northport, NY, and four were studied at The University of Pisa (Italy). The selection criterion was continuous neuroleptic treatment for at least two years. Exclusion criteria were substance abuse, organic brain syndrome, and neurologic or significant medical illness. Signs of TD or neuroleptic-induced parkinsonism were present in some subjects and were not exclusion criteria. The . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?